1月 2026
BASi截至 1月 2026 的總收入為 25M - 50M
BASi 熱門網域產生的總收入
BASi 熱門網域 3 年內的總收入
BASi 熱門網域的總收入
BASi的熱門網域總造訪量
了解BASi市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
BASi的熱門網域平均造訪時長
分析BASi參與度指標。
過去 3 個月平均造訪時長
子公司細目
BASi的熱門網域平均頁面瀏覽量
了解BASi如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自BASi
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞BASi hires Greg Beattie as chief operating officer.Bioanalytical Systems has appointed Greg Beattie as chief operating officer of Inotiv.
2月 15, 2021閱讀更多
新聞BASi hired Daniel Smeak as Vice President, Surgical Models on Dec 30th '20.Bioanalytical Systems, Inc. (NASDAQ: BASI ) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that Daniel Smeak, DVM, ACVS, has joined the Company as Vice President, Surgical Models, effective December 30, 2020.
1月 8, 2021閱讀更多
新聞BASi partnered with Preclinicalresearch on Nov 8th '19.¨ On November 8, 2019, Bioanalytical Systems, Inc. (the “ Company ”), and Bronco Research Services LLC, a wholly owned subsidiary of the Company (the “ Purchaser ”), entered into an Asset Purchase Agreement (the “ Purchase Agreement ”) with Pre-Clinical Research Services, Inc., a Colorado corporation (the “ Seller ”), and its shareholder.
11月 8, 2019閱讀更多
查看所有BASi信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。